Zur Rose adds Promofarma
This article was originally published in OTC Bulletin & The Rose Sheet
Pharmaceutical supply chain disruptor Zur Rose has acquired for an undisclosed sum Spanish e-commerce platform Promofarma, signalling a step change in its international expansion strategy.
You may also be interested in...
Bricks-And-Mortar Pharmacy In The Crosshairs As Zur Rose Aims To Become The Amazon Of European Healthcare
Swiss supply chain disruptor Zur Rose wants to break up the ancient monopoly of European bricks-and-mortar pharmacy and replace it with a tech-driven healthcare offering to rival that of retail giant Amazon, according to a member of the firm’s board, Olaf Heinrich.
As of 5 February, the Scientific Committee on Consumer Safety is evaluating use of titanium dioxide – now officially classified as a Category 2 carcinogen in the EU – in cosmetic products that can expose consumers by way of inhalation. Without a favorable SCCS opinion, the ingredient’s use in those contexts will be banned under Article 15 of the Cosmetics Regulation.
Nanobiotix’s CEO outlines to Scrip how the biotech plans to develop and expand its lead asset into multiple cancer indications, and create a blockbuster.